Charles River Laboratories International, Inc.
CRL- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001100682
In the last 90 days, Charles River Laboratories International, Inc. insiders filed 0 open-market purchases and 9 sales; 569 institutions reported holding it in 13F filings for Q2 2026, worth $12.9B in total; Harris Associates (Oakmark) is the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Charles River Laboratories International, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 665
- −5 vs. Q1 2024
- Shares held
- 52.4M
- +197.2K (+0.4%) vs. Q1 2024
- Total value
- $10.8B
- −$3.30B (−23.4%) vs. Q1 2024
- New holders
- 74
- 266 more added
- Sold out
- 79
- 235 more reduced
5 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 569 | $12.9B |
| Q1 2026 | 560 | $9.86B |
| Q4 2025 | 584 | $10.6B |
| Q3 2025 | 556 | $7.92B |
| Q2 2025 | 519 | $7.73B |
| Q1 2025 | 562 | $8.03B |
| Q4 2024 | 636 | $9.78B |
| Q3 2024 | 629 | $10.3B |
| Q2 2024 | 665 | $10.8B |
| Q1 2024 | 675 | $14.1B |
| Q4 2023 | 634 | $12.3B |
| Q3 2023 | 622 | $10.1B |
| Q2 2023 | 613 | $10.7B |
| Q1 2023 | 623 | $10.3B |
| Q4 2022 | 630 | $10.8B |
| Q3 2022 | 583 | $9.91B |
| Q2 2022 | 629 | $10.4B |
| Q1 2022 | 644 | $13.5B |
| Q4 2021 | 708 | $17.8B |
| Q3 2021 | 679 | $19.3B |
| Q2 2021 | 639 | $17.6B |
| Q1 2021 | 562 | $13.7B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Charles River Laboratories International, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 146,442 | $30.3M | 0.01% | +25,295+20.9% | Added |
| CIBC Private Wealth Group, LLC | 153,062 | $31.0M | 0.06% | +4,418+3.0% | Added |
| Aristotle Capital Boston, LLC | 150,694 | $31.1M | 1.05% | +2,115+1.4% | Added |
| Swiss National Bank | 152,100 | $31.4M | 0.02% | −1,500−1.0% | Reduced |
| 1832 Asset Management L.P. | 160,000 | $33.1M | 0.06% | +160,000 | New |
| Horizon Kinetics Asset Management LLC | 160,381 | $33.1M | 0.58% | +1,170+0.7% | Added |
| Premier Fund Managers Ltd | 160,000 | $33.2M | 1.33% | 00.0% | Unchanged |
| Barclays PLC | 165,205 | $34.1M | 0.02% | +51,731+45.6% | Added |
| Employees Retirement System of Texas | 174,000 | $35.9M | 0.34% | 00.0% | Unchanged |
| Royal Bank of Canada | 175,649 | $36.3M | 0.01% | +2,321+1.3% | Added |
| Jackson Square Partners, LLC | 178,226 | $36.8M | 2.25% | −73,082−29.1% | Reduced |
| Fisher Asset Management, LLC | 183,106 | $37.8M | 0.02% | −1,549−0.8% | Reduced |
| American Capital Management Inc | 183,300 | $37.9M | 1.27% | 00.0% | Unchanged |
| Voya Investment Management LLC | 195,581 | $40.4M | 0.04% | −5,149−2.6% | Reduced |
| Boston Trust Walden Corp | 200,314 | $41.4M | 0.31% | +5,375+2.8% | Added |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 206,014 | $42.6M | 0.11% | +1,970+1.0% | Added |
| Citigroup Inc | 213,353 | $44.1M | 0.04% | +10,736+5.3% | Added |
| Goldman Sachs Group Inc | 218,356 | $45.1M | 0.01% | +69,115+46.3% | Added |
| Bellevue Group AG | 232,702 | $48.1M | 0.78% | +3,005+1.3% | Added |
| Woodley Farra Manion Portfolio Management Inc | 239,771 | $49.5M | 2.69% | −3,389−1.4% | Reduced |
| Manufacturers Life Insurance Company, The | 239,913 | $49.6M | 0.05% | +101,732+73.6% | Added |
| Legal & General Group Plc | 243,637 | $50.3M | 0.01% | −11,593−4.5% | Reduced |
| Raymond James & Associates | 248,112 | $51.3M | 0.03% | −236−0.1% | Reduced |
| UBS Asset Management Americas Inc | 265,259 | $54.8M | 0.02% | +44,573+20.2% | Added |
| Epoch Investment Partners, Inc. | 271,144 | $56.0M | 0.26% | +23,643+9.6% | Added |
| Empower Advisory Group, LLC | 272,601 | $56.3M | 0.21% | +5,808+2.2% | Added |
| Primecap Management Co | 273,730 | $56.5M | 0.04% | −200−0.1% | Reduced |
| Riverbridge Partners LLC | 289,272 | $59.8M | 0.81% | −14,506−4.8% | Reduced |
| Neuberger Berman Group LLC | 307,457 | $63.5M | 0.05% | +40,634+15.2% | Added |
| M.D. Sass Investors Services, Inc. | 308,945 | $63.8M | 5.19% | +159,492+106.7% | Added |
| Van Berkom & Associates Inc. | 318,228 | $65.7M | 1.96% | +6,762+2.2% | Added |
| King Luther Capital Management Corp | 318,346 | $65.8M | 0.30% | −32,859−9.4% | Reduced |
| Envestnet Asset Management Inc | 319,177 | $65.9M | 0.02% | +11,514+3.7% | Added |
| FIL Ltd | 321,945 | $66.5M | 0.07% | −75,100−18.9% | Reduced |
| Ameriprise Financial Inc | 361,849 | $74.8M | 0.02% | +79,113+28.0% | Added |
| Thrivent Financial for Lutherans | 374,659 | $77.4M | 0.16% | −191,205−33.8% | Reduced |
| JPMorgan Chase & Co | 396,986 | $82.0M | 0.01% | +42,558+12.0% | Added |
| Congress Asset Management Co | 443,104 | $91.5M | 0.66% | −10,288−2.3% | Reduced |
| FMR LLC | 457,719 | $94.6M | 0.01% | −7,046−1.5% | Reduced |
| Northern Trust Corp | 457,897 | $94.6M | 0.02% | −1,354−0.3% | Reduced |
| Victory Capital Management Inc | 465,694 | $96.2M | 0.10% | +5,876+1.3% | Added |
| Bank of New York Mellon Corp | 480,342 | $99.2M | 0.02% | +96,319+25.1% | Added |
| Morgan Stanley | 481,774 | $99.5M | 0.01% | +46,715+10.7% | Added |
| Charles Schwab Investment Management Inc | 482,911 | $99.8M | 0.02% | +34,102+7.6% | Added |
| Norges Bank | 514,238 | $106.2M | 0.02% | +58,142+12.7% | Added |
| Dimensional Fund Advisors LP | 561,075 | $115.9M | 0.03% | +93,682+20.0% | Added |
| Wells Fargo & Company | 561,122 | $115.9M | 0.03% | −8,293−1.5% | Reduced |
| SEI Investments Co | 624,800 | $129.1M | 0.18% | +49,451+8.6% | Added |
| Price T Rowe Associates Inc | 640,985 | $132.4M | 0.02% | −681,469−51.5% | Reduced |
| Franklin Resources Inc | 665,148 | $137.4M | 0.04% | +13,343+2.0% | Added |
| Marshall Wace, LLP | 825,905 | $170.6M | 0.24% | +163,056+24.6% | Added |
| Ariel Investments, LLC | 906,137 | $187.2M | 2.03% | −26,670−2.9% | Reduced |
| Mackenzie Financial Corp | 929,160 | $191.9M | 0.29% | −2,637−0.3% | Reduced |
| Bank of America Corp | 974,728 | $201.4M | 0.02% | +85,558+9.6% | Added |
| Invesco Ltd. | 995,912 | $205.7M | 0.04% | +103,388+11.6% | Added |
| Earnest Partners LLC | 1,004,486 | $207.5M | 0.97% | +110,725+12.4% | Added |
| Southpoint Capital Advisors LP | 1,150,000 | $237.6M | 5.91% | +450,000+64.3% | Added |
| Meritage Group LP | 1,182,657 | $244.3M | 6.21% | +3890.0% | Added |
| Geode Capital Management, LLC | 1,216,793 | $250.7M | 0.02% | +30,949+2.6% | Added |
| Allspring Global Investments Holdings, LLC | 1,251,618 | $258.6M | 0.42% | +132,802+11.9% | Added |
| Clearbridge Investments, LLC | 1,368,505 | $282.7M | 0.23% | −144,633−9.6% | Reduced |
| Kayne Anderson Rudnick Investment Management LLC | 1,908,989 | $394.4M | 0.96% | +31,359+1.7% | Added |
| State Street Corp | 2,088,858 | $431.5M | 0.02% | −5,254−0.3% | Reduced |
| BlackRock Inc. | 5,088,017 | $1.05B | 0.02% | −83,767−1.6% | Reduced |
| Vanguard Group Inc | 6,103,449 | $1.26B | 0.02% | +56,982+0.9% | Added |
| Montrusco Bolton Investments Inc. | 0 | $0 | 0.00% | −489,751−100.0% | Sold out |
| William Blair Investment Management, LLC | 0 | $0 | 0.00% | −364,614−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| CTF Capital Management, LP | 0 | $0 | 0.00% | −40,300−100.0% | Sold out |
| Holocene Advisors, LP | 0 | $0 | 0.00% | −32,078−100.0% | Sold out |
| Sivik Global Healthcare LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −21,329−100.0% | Sold out |
| Regency Capital Management Inc. | 0 | $0 | 0.00% | −17,930−100.0% | Sold out |
| Parkman Healthcare Partners LLC | 0 | $0 | 0.00% | −17,697−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −16,780−100.0% | Sold out |
| Royce & Associates LP | 0 | $0 | 0.00% | −15,592−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −13,410−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −13,116−100.0% | Sold out |
| Texas Permanent School Fund | 0 | $0 | 0.00% | −10,602−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −10,600−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −8,720−100.0% | Sold out |
| Montag A & Associates Inc | 0 | $0 | 0.00% | −8,221−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −4,856−100.0% | Sold out |
| Legacy Wealth Asset Management, LLC | 0 | $0 | 0.00% | −3,437−100.0% | Sold out |
| Brasada Capital Management, LP | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −2,970−100.0% | Sold out |
| FDx Advisors, Inc. | 0 | $0 | 0.00% | −2,621−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −2,405−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,069−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −1,745−100.0% | Sold out |
| Baker Tilly Wealth Management, LLC | 0 | $0 | 0.00% | −1,693−100.0% | Sold out |
| Sandy Cove Advisors, LLC | 0 | $0 | 0.00% | −1,538−100.0% | Sold out |
| Terry L. Blaker | 0 | $0 | 0.00% | −1,491−100.0% | Sold out |
| Avestar Capital, LLC | 0 | $0 | 0.00% | −1,287−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −1,217−100.0% | Sold out |
| KCM Investment Advisors LLC | 0 | $0 | 0.00% | −1,172−100.0% | Sold out |
| ASB Consultores, LLC | 0 | $0 | 0.00% | −1,156−100.0% | Sold out |
| Bridgewater Associates, LP | 0 | $0 | 0.00% | −1,100−100.0% | Sold out |
| Ethos Financial Group, LLC | 0 | $0 | 0.00% | −1,093−100.0% | Sold out |
| QRG Capital Management, Inc. | 0 | $0 | 0.00% | −1,047−100.0% | Sold out |